Omada Health (NASDAQ:OMDA) Combines High Growth Momentum with Breakout Setup
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Baird Maintains Neutral on Omada Health, Raises Price Target to $25
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
BTIG Maintains Buy on Omada Health, Raises Price Target to $35
Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
Omada Health Q2 Earnings Call Highlights
Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ...
Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates
Omada Health (NASDAQ:OMDA) Soars on Q2 Beat, Record Margins, and Raised Guidance
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
Barclays Maintains Overweight on Omada Health, Raises Price Target to $25
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.